Global Wearable Health Tech News – June and July 2025

The months of June and July 2025 have been packed with developments in wearable devices and health-sensing technology. This report compiles global news from this period, including major product launches, breakthroughs in wearable health sensors (for glucose, ECG, blood pressure, hydration, and more), key regulatory approvals (FDA and others), emerging market trends and forecasts, recent clinical research findings, and notable expert commentary. The focus is on authoritative sources such as company press releases, medical journals, regulatory announcements, and reputable news outlets. Each section below is structured to provide a clear overview of the latest happenings, with sources cited for verification.

Major Product Launches and Announcements (June–July 2025)

Several companies – from startups to tech giants – unveiled new wearable health-tech products or collaborations in this period. These range from advanced vital-sign monitors to integrated diabetes management devices. The table below summarizes some key announcements:

Table: Selected wearable health-tech product launches and announcements (June–July 2025). These innovations highlight the industry’s focus on non-invasive monitoring, integrated health solutions, and medical-grade wearables.

Advances in Wearable Health-Sensing Technology

Non-Invasive Glucose & Blood Pressure Monitoring: A long-sought “holy grail” in wearables – monitoring blood sugar without needles – took a leap forward. Silicon Valley startup LifePlus announced successful trials of LifeLeaf, a wrist-worn device that continuously measures glucose and blood pressure cufflessly. In multi-center trials (spanning four continents), LifeLeaf’s readings were highly accurate: within ~10.8% of traditional glucometers and with minimal BP error (≈0.03 mmHg on average) medicaleconomics.com medicaleconomics.com. The AI-powered sensor platform requires no fingersticks, no arm cuff, and no calibration, yet closely matched invasive CGMs (only ~8.5% difference vs. Dexcom G6) medicaleconomics.com medicaleconomics.com. Experts hailed it as a “breakthrough… without the usual barriers of needles or cuffs” that could improve patient adherence and early disease detection medicaleconomics.com medicaleconomics.com. This development, alongside ongoing R&D by major brands, signals that non-invasive glucose monitoring is nearing practical reality. (Notably, industry reports suggest Apple is pouring resources into developing a blood-glucose sensor for future Apple Watches ts2.tech.) In diabetes care, another novel approach emerged from Europe/Asia: PharmaSens (Switzerland) and SiBionics (China) are co-developing “niia™ signature,” an all-in-one patch combining a continuous glucose sensor with an insulin pump prnewswire.com prnewswire.com. Unveiled around the American Diabetes Association meeting, this wearable patch aims to automate glucose control and “reduce the daily burden” for insulin users by unifying two devices into one prnewswire.com. These advances suggest that by integrating sophisticated sensors and AI, wearables are moving from wellness gadgets to clinical-grade medical devices for chronic disease management medicaleconomics.com ts2.tech.

Cardiac Monitoring (ECG and Heart Health): Wearable ECG technology continues to mature, both in mainstream smartwatches and new form factors. During CES 2025, for example, France’s Circular unveiled a next-gen smart ring with an onboard ECG sensor capable of detecting atrial fibrillation – reportedly obtaining FDA clearance for its AFib algorithm ts2.tech. This reflects a broader trend of miniaturized, discreet wearables (rings, patches, etc.) achieving capabilities once limited to bulky devices ts2.tech ts2.tech. Meanwhile, clinical evidence is reinforcing the accuracy of wearable heart monitors. A recent study cited by Applied Clinical Trials found that wearable ECG patches detect arrhythmias as accurately as traditional Holter monitors appliedclinicaltrialsonline.com. Similarly, the massive Fitbit Heart Study (over 455,000 participants) published new data in June: it showed that when a wrist wearable’s PPG sensor flags an irregular heart rhythm, users have a high chance (57% within 3 months) of getting another irregular rhythm alert, and longer continuous ECG monitoring substantially increases the likelihood of confirming atrial fibrillation researchgate.net researchgate.net. For instance, a 4-week ECG patch caught AF in ~61% of cases after an initial alert, compared to ~19% with just a one-week monitor researchgate.net researchgate.net. The study concluded that irregular heartbeat notifications from wearables are often valid and recurrent, but confirming AFib may require extended ECG monitoring, underscoring the importance of integrating wearables with medical follow-up researchgate.net. The takeaway: modern wearables (watches, rings, patches) are becoming reliable tools for real-time cardiac monitoring, from consumer wellness to clinical trial settings. Regulators are onboard too – multiple smartwatch ECG apps (Apple, Fitbit, etc.) are FDA-cleared for AFib detection, and companies like Garmin have added ECG features in 2025 models ts2.tech. This convergence of tech and medicine is enabling earlier detection of arrhythmias and more continuous heart health management outside the clinic.

Blood Pressure, Hydration, and Other Sensors: Wearables are also expanding into other vital signs and wellness metrics. Cuffless blood pressure monitoring – once exclusive to bulky machines – is appearing in wearables: as noted above, Biobeat’s chest patch and Huawei’s recent Watch GT series both measure blood pressure without a cuff wearable-technologies.com ts2.tech. Biobeat’s newly launched patch uses photoplethysmography (PPG) and AI to track BP continuously; it secured FDA clearance and European CE-Marking, allowing use in hospitals and at home wearable-technologies.com wearable-technologies.com. This device can effectively turn vital sign checks into a 24/7 automated process, shifting care “from reactive to proactive” by alerting clinicians to blood pressure changes in real time wearable-technologies.com ts2.tech. Another frontier is hydration monitoring – important for athletes, workers, and military personnel. In June, media highlighted emerging solutions like skin patches that sense hydration levels via sweat or interstitial fluid. For example, Australian startup WearOptimo is developing a tiny “Microwearable” patch with microelectrodes that painlessly penetrate the skin’s top layer to measure real-time hydration; the data is analyzed with AI to warn of dehydration before symptoms hit mddionline.com mddionline.com. WearOptimo’s platform, set to launch in coming years, has been trained on over a billion data points to correlate its sensor readings with hydration status mddionline.com mddionline.com. Unlike crude methods (skin pinch, urine color), this approach directly measures physiological signals; the company claims it’s “the only wearable… that genuinely monitors hydration” rather than just sweat rate mddionline.com mddionline.com. While still in development, it exemplifies how next-gen wearables will tackle metrics like hydration, stress, and even metabolic markers. Indeed, industry analysts predict late 2025 devices will push further into medical-grade sensing – blood pressure, hydration, and even fertility tracking – as sensors improve ts2.tech. Already, some fitness wearables track skin temperature, blood oxygen (SpO₂), respiratory rate, stress (HRV), and even sleep apnea risk, turning watches and rings into multiparameter health monitors ts2.tech. Coupled with AI algorithms that interpret these signals (for instance, detecting subtle changes that precede illness ts2.tech), wearables are moving toward an era of “continuous wellness monitoring” ts2.tech – effectively becoming an early-warning system on the body.

Regulatory and Policy Updates on Wearable Health Tech

FDA Clearances and Approvals: June and early July 2025 saw several notable approvals for wearable health devices, underscoring regulators’ growing engagement with this sector. The U.S. Food and Drug Administration (FDA) granted a first-of-its-kind clearance to the Felix NeuroAI Wristband – an AI-driven wearable for treating essential tremor medicaleconomics.com. Announced July 2, this device (from startup Fasikl) delivers personalized neuromodulation through a wristband, providing continuous tremor relief without surgery or drugs medicaleconomics.com medicaleconomics.com. It’s the first wrist-worn therapy cleared for essential tremor, a common movement disorder affecting ~7 million Americans medicaleconomics.com medicaleconomics.com. Clinical data (the TRANQUIL study) showed the device significantly reduced tremors and improved daily function, with no serious side effects medicaleconomics.com medicaleconomics.com – a promising result that opens the door for non-invasive wearables treating neurological conditions. Another FDA nod went to the SONU Band, a wearable headband for nasal congestion/allergies. On June 4, FDA approved an expanded pediatric indication for SONU (by SoundHealth) as an at-home treatment for chronic nasal congestion in ages 12+ contemporarypediatrics.com. This makes SONU the first FDA-approved drug-free solution for allergic rhinitis symptoms contemporarypediatrics.com. The band, worn above the eyebrows, uses personalized acoustic vibrations to clear sinus passages – improving airflow and even boosting CPAP therapy adherence in sleep apnea patients, according to clinical studies contemporarypediatrics.com contemporarypediatrics.com. FDA’s approval via the De Novo pathway highlights the device’s novelty in addressing a significant need (non-pharmaceutical relief for nasal congestion) contemporarypediatrics.com contemporarypediatrics.com. These clearances illustrate regulators’ willingness to embrace wearable therapeutics (not just monitors) that demonstrate safety and efficacy.

Other regions are also advancing oversight of wearables. In Europe, many wearable health gadgets are obtaining CE Marks as medical devices, and standards bodies are considering guidelines for algorithms in consumer health tech. For example, a smart ring pulse oximeter (Viatom O2Ring) was approved by regulators earlier in 2025 for over-the-counter use osteoboost.com, and EU MDR (Medical Device Regulation) compliance is a focus for wearable makers seeking European markets. While no specific EU regulatory events in June–July grabbed headlines, companies like Neurolief have recently secured CE marks for wearable migraine treatments, and such devices are expected to pursue FDA clearance next.

Health Policy and Government Initiatives: On the policy front, the United States government made a splash by openly endorsing wearable health technology as part of public health strategy. U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has launched an initiative to encourage Americans to use wearables for personal health monitoring reuters.com. Testifying before Congress in late June, he stated “my vision is that every American is wearing a wearable within four years” as part of the “Making America Healthy Again” (MAHA) agenda reuters.com. The campaign, which Kennedy described as “one of the biggest” in HHS history, will include a multimillion-dollar advertising effort to popularize health tech gadgets as “cool, modern tools” for tracking diet and vitals axios.com axios.com. The immediate market impact was telling: shares of CGM manufacturers Dexcom and Abbott jumped 10% and 3.6%, respectively, on the news of HHS’s wearable push reuters.com reuters.com. Kennedy argues that wearables can empower individuals to take control of their health – for example, seeing real-time how their food intake affects blood glucose and heart rate – potentially reducing reliance on expensive medications reuters.com reuters.com. “Ozempic costs $1300 a month – if you can achieve the same thing with an $80 wearable, it’s a lot better for the American people,” he remarked, suggesting that HHS is even exploring ways to cover or subsidize such devices reuters.com.

However, this pro-wearable stance comes with caveats and sparked debate among experts. Clinicians and ethicists have cautioned that without proper oversight, a mass rollout of health wearables could backfire axios.com axios.com. One concern is data accuracy: if devices provide unreliable or “confusing” readings, people might misinterpret their health status axios.com. “Providing individuals with reliable, accurate, useful medical information is critically important… [but] unreliable, inaccurate information… can lead them to make poor choices,” warned Purdue biomedical ethics professor Andrew Brightman axios.com axios.com. For instance, a fitness tracker might reassure someone they’re healthy because they exercise and sleep well, causing them to ignore subtle symptoms and delay seeing a doctor axios.com. Another major issue is privacy and data security. Health data from wearables often falls outside HIPAA protections, since it’s user-generated rather than held by a doctor or insurer axios.com. “People think, ‘oh, it’s just my steps or heart rate,’ but it potentially is so much more,” noted attorney Lisa P. Reisz, who explained that companies’ privacy policies (which few read) are the main safeguard – and those can change at any time axios.com axios.com. The prospect of massive personal data collection via wearables has even some of Kennedy’s own allies wary. Kennedy himself acknowledged, “I do not advise anyone to purchase a wearable that does not provide ironclad privacy protections,” emphasizing awareness of data misuse risks axios.com. In sum, the U.S. government’s embrace of wearable tech is a significant validation of the field, but it also brings regulatory scrutiny to issues of accuracy, privacy, and equitable access (Kennedy later clarified that wearables “are not for everyone” due to cost and privacy concerns, and that the campaign will focus on empowering individuals to choose the right tools for themselves axios.com axios.com). We can expect continued dialogue between policymakers, industry, and healthcare providers to ensure that wearable health devices deliver on their promise in a safe and secure way.

Market Trends and Analyst Insights

The global wearable technology market in mid-2025 continues to grow, though signs of maturation are appearing as the sector moves from novelty to mainstream. Shipments of wearables worldwide are projected to exceed 500 million units in 2025, according to IDC, with consumer demand still rising but at a slower pace ts2.tech ts2.tech. IDC forecasts roughly 3.9% year-over-year growth in 2025, a deceleration compared to ~6% growth in 2024, as key segments like fitness trackers and smartwatches approach saturation in some markets ts2.tech. Nonetheless, any growth on such a large base is significant – the industry is on track to generate tens of billions of dollars in sales (one estimate puts the global wearables market at ~$150B by 2026) and remains one of the fastest-evolving consumer electronics sectors. Analysts note that the next wave of expansion may come from niche and underserved segments: for example, children’s wearables, devices specifically for women’s health (menstrual trackers, fertility monitors), and medical-grade wearables for seniors or patients ts2.tech. These categories are ripe for innovation and could bring new demographics into the wearables fold.

Another growth driver is making wearables “indispensable for healthcare,” not just nice-to-have gadgets ts2.tech. Industry strategy reflects this, with big tech acquisitions (Google’s $2.1B acquisition of Fitbit in 2021, Apple’s investments in health R&D, etc.) and partnerships between medtech and consumer tech companies. The overarching trend is a blurring of lines between consumer wellness devices and clinical devices, as seen in the product launches and FDA approvals this summer. Many wearable makers are seeking regulatory clearances for advanced features (e.g., ECG, AFib detection, blood pressure) to increase credibility and usage in healthcare programs ts2.tech. “Digital health is going to be huge,” observes Avi Greengart, lead analyst at Techsponential, noting the surge in devices that track health markers and help people manage wellness at home ts2.tech. Users are becoming more health-conscious and data-driven, creating opportunity for wearables that provide actionable health insights rather than just step counts. COVID-19 also accelerated acceptance of remote monitoring, a trend that continues as healthcare systems explore wearables for telehealth and chronic disease management.

In terms of product form factors and competition, 2025 has seen wearables diversify beyond the wrist. Smartwatches remain the flagship category – Apple, Samsung, and Huawei all recently introduced models with incremental improvements in sensors and battery life. Notably, Apple Watch Series 10 (late 2024) helped Apple briefly reclaim the top global smartwatch spot ts2.tech, featuring minor upgrades but paving the way for expected bigger changes in Series 11 (rumored for Fall 2025, possibly adding a new sensor like glucose or a micro-LED display) ts2.tech. Samsung and Google (Fitbit) are close followers, and Garmin holds a strong niche with health-focused sports wearables. However, new form factors are where much innovation is happening: smart rings (like Oura Ring, Circular Ring) are gaining popularity for their discreetness and now boast capabilities like ECG and oxygen monitoring ts2.tech. Ear-based wearables and hearables are also merging with health – for example, Apple’s AirPods Pro were updated with a “conversation boost” feature and have even been cleared as OTC hearing aids in the U.S., showing how audio devices can double as health aids ts2.tech ts2.tech. Even smart glasses are re-emerging, with Google and others teasing lightweight AR glasses that could incorporate fitness or health functions in the future ts2.tech ts2.tech. The expandability of the wearable concept – from watches to rings, patches, clothing, and beyond – means the market is not one-size-fits-all. IDC’s Jitesh Ubrani notes that consumers are responding to these new options: “We’re seeing innovation in form factor… the rise of smart rings shows that miniaturized, discreet wearables are resonating with consumers,” he said ts2.tech. This diversification not only fuels unit sales but also engages style- or privacy-conscious users who may not want a conspicuous smartwatch.

Furthermore, AI and data services are an increasingly important part of the wearables market. Many devices now come bundled with subscription apps or cloud services that analyze the troves of data they collect. Companies are leveraging AI for features like personalized coaching (e.g., Apple’s new Workout Buddy in watchOS 26 uses AI-generated voice feedback based on your fitness data apple.com apple.com) or for health anomaly detection. There is a growing ecosystem of third-party digital health apps that integrate wearable data for managing conditions like diabetes, hypertension, or mental health. All these factors contribute to healthy revenue streams and user engagement beyond the initial device sale.

In summary, the mid-2025 wearable tech landscape is one of moderate but steady growth in shipments, intensifying competition (especially in health features), and a clear pivot towards healthcare integration. The market’s center of gravity is shifting from pure fitness trackers to a broader array of devices that people use for comprehensive wellness and medical purposes. With consumers willing to share data with doctors (a recent survey indicates 94% of smartwatch owners are open to sharing their health data if it improves care usnews.com birmingham.ac.uk) and healthcare providers increasingly trusting wearable data, analysts remain optimistic. They forecast that wearables will continue to be one of the key enablers of the preventive, personalized health paradigm that is rapidly emerging ts2.tech ts2.tech.

Recent Research and Clinical Studies (June–July 2025)

Academic and clinical research on wearable health tech has been prolific, reflecting the technology’s growing importance in medicine. A few highlights from studies published or reported in June–July 2025:

• Fitbit Heart Study – Atrial Fibrillation Detection: As mentioned earlier, the Fitbit-sponsored study (published in Circulation: Arrhythmia and Electrophysiology, June 2025) provided new insights into how wearables can detect and validate atrial fibrillation (AF). It found that wrist wearables using photoplethysmography (PPG) can successfully flag irregular heart rhythms, and that such irregular rhythm notifications (IRNs) often recur in users without diagnosed AF researchgate.net researchgate.net. Among participants who got an initial irregular rhythm alert and then wore an ECG patch, 57.2% had another irregular rhythm detected within 3 months researchgate.net. The study also quantified how various ECG monitoring strategies confirm AF: a single 10-second spot ECG would catch only ~7.6% of AF cases after an alert, whereas a 4-week continuous ECG patch caught about 61% of cases researchgate.net researchgate.net. These findings underscore the value of wearables for early AF screening in large populations while highlighting that longer continuous monitoring yields the best diagnostic yield for intermittent AF researchgate.net researchgate.net. The study helps inform protocols on following up wearable alerts with medical-grade confirmation.
• Wearable ECG Accuracy in Clinical Trials: A report from the Drug Information Association (DIA) Annual Meeting (late June 2025) discussed how wearable ECG devices are enhancing cardiac safety monitoring in pharmaceutical trials. One cited study showed that a wearable ECG patch detected arrhythmias as accurately as traditional methods like Holter monitors appliedclinicaltrialsonline.com. This is significant for clinical research – it suggests trial sponsors can rely on comfortable wearable patches to gather continuous ECG data from participants at home, potentially replacing clunky monitors and reducing the need for site visits. The article noted that continuous, real-world data from wearables can improve detection of transient cardiac events (e.g., drug-induced arrhythmias) that might be missed by periodic clinic ECGs appliedclinicaltrialsonline.com appliedclinicaltrialsonline.com. It also highlighted that using wearables can boost patient compliance (since they’re less burdensome) and even accelerate trials, as data flows in remotely and reliably appliedclinicaltrialsonline.com appliedclinicaltrialsonline.com. These findings are reinforcing confidence in wearable biosensors for clinical-grade monitoring – not just for AF, but for QT prolongation or other heart effects in new drug evaluations appliedclinicaltrialsonline.com appliedclinicaltrialsonline.com.
• Early Illness Detection via Wearables: Building on lessons from the pandemic, researchers are finding that wearables can detect signs of infection or illness before symptoms arise. In June 2025, a Texas A&M study reported that changes in metrics like heart rate variability, skin temperature, and resting heart rate – as captured by common smartwatches – can signal viral infection (like flu or COVID-19) hours to days in advance of noticeable symptoms stories.tamu.edu. The ability of wearables to serve as an “early warning system” for illness could enable faster isolation or treatment, a concept supported by similar studies in Stanford and Mount Sinai in recent years. In fact, a piece in PNAS Nexus (June 2025) argued that everyday smartwatches are so accurate in detecting presymptomatic infection that they could help terminate pandemics by alerting individuals to isolate early sciencedaily.com sciencedaily.com. This line of research is still evolving, but it demonstrates the potential public health value of wearables beyond individual wellness.
• Other Notable Studies: Researchers are also exploring wearables in diverse contexts. A University of Birmingham study (UK) found that providing smartwatches with coaching apps to people with Type 2 diabetes helped increase their physical activity and improved glucose control, suggesting wearables can be effective tools in diabetes self-management programs birmingham.ac.uk. Another interdisciplinary study used wearable motion sensors and smartphone games to identify behavioral patterns associated with ADHD in children (published in JMIR mHealth, July 2025), pointing to a future where wearables assist in mental and developmental health diagnostics. Overall, the scientific literature in mid-2025 is validating many of the claims of wearable tech and even discovering new applications, from remote patient monitoring of post-operative recovery wearable-technologies.com wearable-technologies.com to using wearables data for epidemiology and population health.

Expert Commentary and Industry Perspectives

Throughout this period, experts from various domains – medicine, technology, and policy – have shared insights on the wearable health tech boom:

• Medical Experts: Clinicians emphasize both the promise and the precautions needed with health wearables. “Wearable devices may facilitate identifying individuals with undiagnosed AF,” wrote cardiologists in the Fitbit Heart Study, noting the high positive predictive value (98%) of consecutive irregular rhythm alerts for actual AF on a patch ECG researchgate.net researchgate.net. At the same time, physicians like Purdue’s Andrew Brightman caution that wearables must deliver reliable data: “supporting health and well-being” with personal devices is great “if [the data] is reliable,” but misleading readings could cause false reassurance or panic axios.com. Doctors are also excited by therapeutic wearables – neurologist Rajesh Pahwa lauded the Felix tremor wristband as “a significant step forward… [when] pharma helps less than 50% of patients and brain surgery, while effective, has risks” medicaleconomics.com medicaleconomics.com. The consensus among healthcare professionals is that wearable tech can be a powerful adjunct to care if validated and integrated properly.
• Industry Analysts and Executives: Tech industry watchers are bullish on the trend of health-focused wearables. Avi Greengart (Techsponential) has repeatedly observed that digital health is the next big wave: “Digital health is going to be huge,” he said, pointing to the explosion of devices that track everything from heart rhythms to stress and enable at-home wellness management ts2.tech. Jitesh Ubrani (IDC) has commented on the diversification of device types, noting that smart rings and other novel wearables are gaining traction by offering more discreet and fashion-friendly options without sacrificing functionality ts2.tech. Executives at wearable firms also stress the life-changing potential of their innovations. For instance, the CEO of PharmaSens, Marcel Both, stated that the all-in-one insulin+CGM patch is aimed at “a fully integrated, discreet, and intuitive insulin-therapy system,” achieving a longstanding goal in diabetes care prnewswire.com prnewswire.com. Biobeat’s team highlighted how eliminating cords and cuffs from vital sign monitoring can transform patient care: “By eliminating the cords, cuffs, and guesswork, our technology ensures patients receive timely, precise care – whether in a hospital bed or recovering at home,” a Biobeat representative said of their FDA-cleared patch wearable-technologies.com ts2.tech. These statements reflect a genuine belief in the value proposition of medical-grade wearables.
• Policy Makers: Government figures like RFK Jr. have been vocal as well. Kennedy’s bold goal to have every American who wants one equipped with a health wearable within a few years reuters.com, and his framing of tech as a cheaper preventive tool compared to pharmaceuticals (e.g., wearables vs weight-loss drugs) reuters.com, have sparked conversation about the government’s role in digital health. His Surgeon General nominee, Dr. Casey Means (a co-founder of Levels Health, a wearable glucose monitoring startup), is herself an advocate for using continuous data to guide nutrition and lifestyle axios.com. This indicates that the public sector in the U.S. is aligning with the wearable trend, potentially through funding, coverage decisions, or national challenges to improve health metrics via tech.
• Privacy and Ethics Advocates: Experts in data privacy remind us that the convenience of wearable health data comes with trade-offs. Lisa Pierce Reisz, a privacy law expert, noted that data from consumer wearables “isn’t subject to HIPAA” once it leaves the medical realm, meaning users rely on company policies to protect their information axios.com. There is a call for stronger standards and possibly regulatory oversight on health apps and wearables to ensure sensitive biometric data is safeguarded. Cybersecurity experts have also weighed in, warning that the more health data wearables collect, the more attractive a target they become for hackers – underscoring the need for robust encryption and user control over data sharing axios.com axios.com.

In conclusion, the expert community – from doctors to analysts to regulators – largely agrees that wearable health tech is at a pivotal moment. The technology has proven its worth in many areas (fitness, cardiology, diabetes, etc.), and with proper validation, it is transitioning into mainstream healthcare. The excitement is palpable: wearables are envisioned as key tools for prevention, personalized treatment, and patient engagement. Yet, experts urge a balanced approach that addresses accuracy, privacy, and equity. As one tech commentator aptly put it, “Wearable technology is revolutionizing the way we interact with devices, offering convenience and functionality in compact forms… shaping a new era of wearable gadgets with enhanced features” ts2.tech. The events of June and July 2025 clearly demonstrate that this revolution is well underway, with the world’s leading minds working to ensure it improves health outcomes for individuals and society at large.

Sources: The information in this report is drawn from a variety of authoritative sources, including company press releases (e.g., PR Newswire announcements of PharmaSens/SiBionics prnewswire.com prnewswire.com and Wearable Devices Ltd. globenewswire.com globenewswire.com), industry news outlets (Wearable Technologies wearable-technologies.com wearable-technologies.com), peer-reviewed medical journals (e.g., Circulation for the Fitbit Heart Study researchgate.net researchgate.net), regulatory announcements (FDA clearance news via Medical Economics medicaleconomics.com medicaleconomics.com and Contemporary Pediatrics contemporarypediatrics.com contemporarypediatrics.com), and analyses by reputable organizations (IDC forecast via TS2 tech report ts2.tech, expert quotes via Axios axios.com axios.com and Reuters reuters.com reuters.com, among others). These sources are cited in-text with the “【†】” notation for verification and further reading. The convergence of evidence from these multiple channels paints a comprehensive picture of the wearable health tech landscape as of mid-2025.